Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
New polymeric heart valve implanted for first time | AI model for heart attack assessments impresses
Monday, July 3, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

New polymeric heart valve, designed to grow with pediatric patients, implanted for first time

The new-look pulmonary valve features a proprietary bi-leaflet design and was designed to grow with the patient, limiting the need for repeat surgeries.

READ MORE >
MASA Valve PECA Labs polymeric pulmonary valve Children’s Hospital of Philadelphia. The MASA Valve is a polymeric pulmonary valve designed and manufactured by Pennsylvania-based PECA Labs. It features a proprietary bi-leaflet design and was designed to grow with the patient, limiting the need for repeat surgeries. While the MASA Valve is not yet fully approved by the U.S. Food and Drug Administration (FDA), it has received the agency’s humanitarian use device and investigation device exemptions.
Share on Twitter Share on Facebook Share on Linkedin

New polymeric heart valve, designed to grow with pediatric patients, implanted for first time

Share on Twitter Share on Facebook Share on Linkedin
MASA Valve PECA Labs polymeric pulmonary valve Children’s Hospital of Philadelphia. The MASA Valve is a polymeric pulmonary valve designed and manufactured by Pennsylvania-based PECA Labs. It features a proprietary bi-leaflet design and was designed to grow with the patient, limiting the need for repeat surgeries. While the MASA Valve is not yet fully approved by the U.S. Food and Drug Administration (FDA), it has received the agency’s humanitarian use device and investigation device exemptions.
The new-look pulmonary valve features a proprietary bi-leaflet design and was designed to grow with the patient, limiting the need for repeat surgeries.
READ MORE >

AI model outperforms researchers’ ‘wildest dreams’ with accurate heart attack assessments

The algorithm, developed using data from more than 7,00 chest pain patients, performed better than multiple techniques currently used to evaluate cardiac events. 

READ MORE >
AI artificial intelligence stethoscope doctor
Share on Twitter Share on Facebook Share on Linkedin

AI model outperforms researchers’ ‘wildest dreams’ with accurate heart attack assessments

Share on Twitter Share on Facebook Share on Linkedin
AI artificial intelligence stethoscope doctor
The algorithm, developed using data from more than 7,00 chest pain patients, performed better than multiple techniques currently used to evaluate cardiac events. 
READ MORE >

Featured Articles

Cardiologists, radiologists say EPA’s new sterilization proposal could put patients at risk

The primary concern is that sterilization facilities and healthcare providers would not have enough time to adapt to the proposal. Devices impacted would include pacemakers, angioplasty balloons and catheters, just to name a few. 

READ MORE >
The Philips Verisight 3D/4D ICE catheter can help guide LAA occlusion and TEER procedures without the need for TEE.
Share on Twitter Share on Facebook Share on Linkedin

Cardiologists, radiologists say EPA’s new sterilization proposal could put patients at risk

Share on Twitter Share on Facebook Share on Linkedin
The Philips Verisight 3D/4D ICE catheter can help guide LAA occlusion and TEER procedures without the need for TEE.
The primary concern is that sterilization facilities and healthcare providers would not have enough time to adapt to the proposal. Devices impacted would include pacemakers, angioplasty balloons and catheters, just to name a few. 
READ MORE >

FDA approves first cellular therapy to treat type 1 diabetes

The new therapy, made from the pancreatic cells of deceased donors, is designed to help adult type 1 diabetes with severe hypoglycemia go a year or longer without needing to take insulin. 

READ MORE >
The FDA has approved donislecel, a new pancreatic islet cellular therapy made from the pancreatic cells of deceased donors, for the treatment of type 1 diabetes among adult patients with severe hypoglycemia. Lantidra
Share on Twitter Share on Facebook Share on Linkedin

FDA approves first cellular therapy to treat type 1 diabetes

Share on Twitter Share on Facebook Share on Linkedin
The FDA has approved donislecel, a new pancreatic islet cellular therapy made from the pancreatic cells of deceased donors, for the treatment of type 1 diabetes among adult patients with severe hypoglycemia. Lantidra
The new therapy, made from the pancreatic cells of deceased donors, is designed to help adult type 1 diabetes with severe hypoglycemia go a year or longer without needing to take insulin. 
READ MORE >

In Case You Missed It

FDA approves colchicine, the first anti-inflammatory drug for treating cardiovascular disease

The FDA's approval of colchicine, which is marketed and sold under the name Lodoco, is expected to have a big impact on cardiac care and outcomes.

READ MORE >
The U.S. Food and Drug Administration (FDA) priority review, the FDA has cleared the Agepha Pharma USA LLC's drug Lodoco (colchicine) as the first anti-inflammatory atheroprotective cardiovascular treatment. Colchicine prevents coronary artery plaque inflammation, heart inflammation. Colchicine for coronary artery disease. Colchicine for coronary inflammation FDA Approves Colchicine for Decreasing CV Events FDA Approves Colchicine for decreasing inflammation caused by coronary atherosclerosis.
Share on Twitter Share on Facebook Share on Linkedin

FDA approves colchicine, the first anti-inflammatory drug for treating cardiovascular disease

Share on Twitter Share on Facebook Share on Linkedin
The U.S. Food and Drug Administration (FDA) priority review, the FDA has cleared the Agepha Pharma USA LLC's drug Lodoco (colchicine) as the first anti-inflammatory atheroprotective cardiovascular treatment. Colchicine prevents coronary artery plaque inflammation, heart inflammation. Colchicine for coronary artery disease. Colchicine for coronary inflammation FDA Approves Colchicine for Decreasing CV Events FDA Approves Colchicine for decreasing inflammation caused by coronary atherosclerosis.
The FDA's approval of colchicine, which is marketed and sold under the name Lodoco, is expected to have a big impact on cardiac care and outcomes.
READ MORE >

Heart damage after TAVR: Follow-up imaging helps cardiologists anticipate problems

While cardiac damage reverses in many patients following treatment, it can actually continue to get worse in others. 

READ MORE >
A TAVR procedure being performed at Northwestern Medicine in Chicago.
Share on Twitter Share on Facebook Share on Linkedin

Heart damage after TAVR: Follow-up imaging helps cardiologists anticipate problems

Share on Twitter Share on Facebook Share on Linkedin
A TAVR procedure being performed at Northwestern Medicine in Chicago.
While cardiac damage reverses in many patients following treatment, it can actually continue to get worse in others. 
READ MORE >

In Other News

SEC nails former Pfizer employee for insider trading ahead of COVID drug announcement

The senior statistician purchased short-term stock options, including some that expired the next day, after allegedly being made aware of Paxlovid’s success in clinical trials ahead of a public announcement.

READ MORE >
Stocks
Share on Twitter Share on Facebook Share on Linkedin

SEC nails former Pfizer employee for insider trading ahead of COVID drug announcement

Share on Twitter Share on Facebook Share on Linkedin
Stocks
The senior statistician purchased short-term stock options, including some that expired the next day, after allegedly being made aware of Paxlovid’s success in clinical trials ahead of a public announcement.
READ MORE >

Women strongly prefer contrast-enhanced mammography over breast MRI for supplemental screening

The findings were reached using an analytic hierarchy process, which can help physicians review options with patients who have never experienced either exam.

READ MORE >
mammogram mammography breast cancer
Share on Twitter Share on Facebook Share on Linkedin

Women strongly prefer contrast-enhanced mammography over breast MRI for supplemental screening

Share on Twitter Share on Facebook Share on Linkedin
mammogram mammography breast cancer
The findings were reached using an analytic hierarchy process, which can help physicians review options with patients who have never experienced either exam.
READ MORE >

Industry News

 

Cassling connects cardiologists with revolutionary AI software

The Midwest company will begin offering EchoSolv, an artificial intelligence clinical decision support platform designed to help detect severe aortic stenosis, to providers throughout the country.     
READ MORE >
 

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

News Alert: CMS to cover cardiac ablations performed in ambulatory surgical centers
The first heart device of its kind | Stem cell patch impresses | FDA sees promise in new therapy | MAC linked to major risks
Medtronic beats expectations | GLP-1 drugs & stroke | Historic hospital pauses transplant program | Boston Scientific & Epic
Week in Review: Myval TAVR valve's strong performance | Drones deliver AEDs | Did Boston Scientific make the right call?
AI flags high-risk coronary plaques | Siemens Healthineers & Boston Scientific work together | FDA clears new software
FDA clears smart shirt | Did Boston Scientific make the right call on TAVR? | Progress for heart failure drug | Beta-blockers
CCTA in the cath lab | Medicare covers renal denervation | Biodegradable device shows promise | TCT 2025 | Is fasting necessary?

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …42
    • Page 43
    • Page 44
    • Page 45
    • Current page 46
    • Page 47
    • Page 48
    • Page 49
    • Page 50 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup